Isolation and Characterization of Cytotoxic Compounds from Detarium microcarpum Guill. and Perr. Stem Bark

Kayode Muritala Salawu1, Omonike Oluyemisi Ogbole2, Oyindamola Oduola Abiodun3

  • 1Department of Pharmacognosy and Drug Development, University of Ilorin, Ilorin, Nigeria.

Abstract

Insights

Detarium microcarpum compounds show potent oral cancer cell cytotoxicity and selectivity. These natural agents offer a promising, less toxic alternative to conventional chemotherapy.

Area of Science:

  • Phytochemistry
  • Pharmacology
  • Cancer Research

Background:

  • High cancer mortality necessitates safer chemotherapeutic agents with improved specificity.
  • Current treatments often cause toxicity, driving demand for selective anticancer drugs.

Purpose of the Study:

  • To evaluate the cytotoxic potential of Detarium microcarpum (DMS).
  • To isolate and characterize cytotoxic compounds from DMS with enhanced selectivity profiles.

Main Methods:

  • Detarium microcarpum stem bark was extracted and fractionated.
  • Cytotoxicity of extracts, fractions, and isolated compounds was assessed against human oral, breast, and cervical cancer cell lines, alongside healthy non-cancer cells.
  • Compounds were isolated from dichloromethane and ethyl acetate fractions.

Main Results:

  • Seven compounds were isolated: methyl gallate, eriodictyol, quercetin, quebrachitol, catechin, catechin gallate, and gallic acid.
  • Compounds showed potent cytotoxicity against oral cancer cells (CAL27), with methyl gallate and quercetin exhibiting the highest activity (IC50 values 89.57±1.98μM and 78.19±1.49μM, respectively).
  • All tested compounds demonstrated selectivity, with no significant toxicity observed in healthy non-cancer (3T3) cells.

Conclusions:

  • Isolated compounds from Detarium microcarpum exhibit specific anticancer activity against oral cancer.
  • These compounds display high selectivity, targeting cancer cells while sparing healthy cells, indicating a favorable safety profile.

Related Concept Videos